Henry S Shen, Age 70241 Heatherstone Way, Lancaster, PA 17601

Henry Shen Phones & Addresses

241 Heatherstone Way, Lancaster, PA 17601 (717) 333-1831

1711 Cambridge St, Philadelphia, PA 19130

Vallejo, CA

Oakland, CA

241 Heatherstone Way, Lancaster, PA 17601

Work

Company: Ta chen international, inc Jul 2010 Position: Import assistant

Education

School / High School: UNIVERSITY OF CALIFORNIA- Irvine, CA 2009 Specialities: Master in Business Administration in Business Administration

Skills

Proficient with PowerPoint • Word • Excel • Outlook • Internet Explorer • Netscape • Adobe Acrobat • EndNote • PubMed • Photoshop • Visual Basic • Language R • Siebel • and SBT system.

Mentions for Henry S Shen

Henry Shen resumes & CV records

Resumes

Henry Shen Photo 26

Usaf

Position:
Plans & Programs Flight Chief at United States Air Force
Location:
Honolulu, Hawaii
Industry:
Government Administration
Work:
United States Air Force since Dec 2012
Plans & Programs Flight Chief
Deloitte Consulting Oct 2010 - Dec 2012
Consultant
United States Air Force, Davis-Monthan AFB, AZ Jun 2006 - Oct 2010
Captain, Contracting Officer
Air Force ROTC Aug 2005 - Dec 2005
Cadet Colonel, Wing Commander and Executive Officer
Education:
Miami University 2002 - 2006
Bachelor of Science degree, Economics
Brecksville-Broadview Heights High School
Henry Shen Photo 27

Analyst At Blackrock

Position:
Analyst at BlackRock
Location:
New York, New York
Industry:
Investment Management
Work:
BlackRock since Jun 2012
Analyst
Duke University: Department of Biomedical Engineering Apr 2010 - Feb 2012
Undergraduate Researcher
BlackRock Jun 2011 - Sep 2011
Summer Analyst
DBS Bank Jul 2010 - Aug 2010
Summer Analyst
Taiwanese Army Sep 2008 - Sep 2009
Military Police Sergeant
Education:
Duke University 2007 - 2012
B.S.E/B.S, Biomedical Engineering, Economics
Peddie School 2003 - 2007
High School
Henry Shen Photo 28

Henry Shen - Orange, CA

Work:
TA CHEN INTERNATIONAL, INC Jul 2010 to 2000
Import Assistant
TA CHEN INTERNATIONAL, INC Sep 2005 to 2000
System Analyst
UC BERKELEY, EAST ASIAN LIBRARY - Berkeley, CA Oct 2004 to May 2005
Assistant I
UC-BERKELEY, DEPARTMENT OF PUBLIC HEALTH - Berkeley, CA Nov 2003 to Sep 2004
Lab Assistant
RELOACTION - Pleasanton, CA Mar 2003 to Jun 2003
Marketing Intern
PREVENTION RESEARCH CENTER - PACIFIC INSTITUTE - Berkeley, CA Oct 2002 to Dec 2002
Research assistant
A W INSURANCE SERVICES, INC - Anaheim, CA Jun 2001 to Sep 2001
Insurance Market Research and Receptionist
ORANGE COAST COLLEGE TUTORING CENTER - Costa Mesa, CA Aug 2000 to Dec 2000
Administrative Assistant
COOPERATIVE BANK Jun 2000 to Sep 2000
Savings and Loan Intern
Education:
UNIVERSITY OF CALIFORNIA - Irvine, CA 2009 to 2012
Master in Business Administration in Business Administration
UNIVERSITY OF CALIFORNIA - Berkeley - Berkeley, CA 2001 to 2005
BA in Econimics
UNIVERSITY OF CALIFORNIA - Berkeley - Berkeley, CA 2001 to 2005
BA in Statistics
Skills:
Proficient with PowerPoint, Word, Excel, Outlook, Internet Explorer, Netscape, Adobe Acrobat, EndNote, PubMed, Photoshop, Visual Basic, Language R, Siebel, and SBT system.

Publications & IP owners

Us Patents

Bsl3 Polypeptides

US Patent:
7723479, May 25, 2010
Filed:
Sep 6, 2007
Appl. No.:
11/900026
Inventors:
Glen Eugene Mikesell - Pacifica CA, US
Han Chang - Princeton Junction NJ, US
Joshua N. Finger - Spring City PA, US
Guchen Yang - Princeton NJ, US
Robert James Peach - San Diego CA, US
Henry Shen - Princeton NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07K 14/705
US Classification:
530350
Abstract:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.

B7-Related Nucleic Acids And Polypeptides Useful For Immunomodulation

US Patent:
2003003, Feb 13, 2003
Filed:
Feb 15, 2002
Appl. No.:
10/077023
Inventors:
Glen Mikesell - Hamilton NJ, US
Henry Shen - Princeton NJ, US
International Classification:
A61K039/395
C07H021/04
C12P021/04
C12N001/21
C12N005/04
C12N005/06
US Classification:
424/178100, 435/069700, 435/325000, 435/320100, 435/252300, 435/254200, 435/410000, 536/023200, 530/350000, 530/388100
Abstract:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.

High Throughput Assay For N-Sulfotransferase Activity Of Glucosaminyl N-Deacetylase/N-Sulfotransferases

US Patent:
2003010, Jun 12, 2003
Filed:
Oct 3, 2002
Appl. No.:
10/263970
Inventors:
Guchen Yang - Morrisville PA, US
Peter Kiener - Doylestown PA, US
Henry Shen - Princeton NJ, US
International Classification:
A61K031/66
C12Q001/34
US Classification:
514/102000, 435/018000
Abstract:
Assays for N-sulfotransferase activity of glucosaminyl N-deacetylase/N-sulfotransferases (NDSTs) include transferring a radiolabeled sulfate from a sulfate donor to a polysaccharide acceptor in the presence of an NDST enzyme to form a radiolabeled sulfated polysaccharide, the radiolabeled sulfated polysaccharide which when bound to a potentially scintillating particulate within an activating distance emits a detectable signal indicative of N-sulfotransferase activity. The assay provides high throughput assays for screening inhibitors that block N-sulfotransferase activity of an NDST. Specific compounds that inhibit N-sulfotransferase activity of an NDST and therapeutic uses of these compounds are disclosed.

B7-Related Nucleic Acids And Polypeptides Useful For Immunomodulation

US Patent:
2006015, Jul 20, 2006
Filed:
Feb 2, 2006
Appl. No.:
11/346468
Inventors:
Glen Mikesell - Hamilton NJ, US
Henry Shen - Princeton NJ, US
International Classification:
A61K 39/395
C07H 21/04
C12P 21/06
C07K 14/74
C07K 16/28
US Classification:
424144100, 435069100, 435320100, 435325000, 530350000, 530388220, 536023500
Abstract:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.

B7-Related Nucleic Acids And Polypeptides Useful For Immunomodulation

US Patent:
2010012, May 20, 2010
Filed:
Feb 7, 2008
Appl. No.:
12/069064
Inventors:
Glen E. Mikesell - Pacifica CA, US
Henry Shen - Princeton NJ, US
Han Chang - Princeton Junction NJ, US
Joshua N. Finger - Spring City PA, US
Guchen Yang - Princeton NJ, US
Robert James Peach - San Diego CA, US
International Classification:
C07K 7/06
C07K 7/08
C07K 5/06
C07K 5/08
C07K 5/10
C07K 14/00
C07K 16/00
C07C 211/00
US Classification:
530324, 530300, 530331, 530330, 530329, 530328, 530327, 530326, 530325, 5303871, 562553
Abstract:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.

B7-Related Nucleic Acids And Polypeptides Useful For Immunomodulation

US Patent:
2010013, Jun 3, 2010
Filed:
Feb 5, 2010
Appl. No.:
12/701119
Inventors:
Glen Eugene Mikesell - Pacifica CA, US
Han Chang - Princeton Junction NJ, US
Joshua N. Finger - Spring City PA, US
Guchen Yang - Princeton NJ, US
Robert James Peach - San Deigo CA, US
Henry Shen - Princeton NJ, US
International Classification:
G01N 33/53
C07K 16/00
C12N 5/16
US Classification:
435 71, 5303879, 5303873, 435326
Abstract:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.

B-7 Related Nucleic Acids And Polypeptides Useful For Immunomodulation

US Patent:
2011029, Dec 1, 2011
Filed:
May 20, 2010
Appl. No.:
12/783968
Inventors:
Glen E. Mikesell - Pacifica CA, US
Henry Shen - Princeton NJ, US
Han Chang - Princeton Junction NJ, US
Joshua N. Finger - Spring City PA, US
Guchen Yang - Princeton NJ, US
Robert James Peach - San Diego CA, US
International Classification:
C12P 21/00
C12N 1/19
C12N 1/21
C12N 1/15
C12N 15/62
C12N 5/10
US Classification:
435 696, 536 234, 4353201, 435 697, 435326, 435325, 435348, 435419, 4352523, 43525411, 4352542, 435366, 43525233, 43525231, 43525421, 435365, 435367, 435358, 4352544, 435357
Abstract:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.

B7-Related Nucleic Acids And Polypeptides Useful For Immunomodulation

US Patent:
2012032, Dec 27, 2012
Filed:
Dec 20, 2011
Appl. No.:
13/331540
Inventors:
Glen Eugene Mikesell - Pacifica CA, US
Han Chang - Princeton Junction NJ, US
Joshua N. Finger - Spring City PA, US
Guchen Yang - Princeton NJ, US
Robert James Peach - San Diego CA, US
Henry Shen - Princeton NJ, US
International Classification:
C07K 14/435
C07H 21/04
US Classification:
530350, 536 235
Abstract:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.